Dai H, Zhang S, Tian M, Yang P, Yang G, Li L, Liu D, Li K, Li S, Yang M. Netrin 4 is a novel cytokine associated with oxidative stress and insulin resistance in obese individuals.
Diabetes Res Clin Pract 2025;
223:112166. [PMID:
40204125 DOI:
10.1016/j.diabres.2025.112166]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/20/2024] [Revised: 03/27/2025] [Accepted: 04/06/2025] [Indexed: 04/11/2025]
Abstract
BACKGROUND
Netrin 4 (NTN4) has been reported to be involved in a variety of pathophysiological processes, such as the occurrence and development of tumors, viral replication and infection, and diabetic retinopathy. However, the relationships between NTN4 and metabolic diseases have not been reported.
METHODS
The PhenoScanner tool and R language were used for bioinformatics analysis. Serum NTN4 was measured by ELISA in 211 healthy women and 193 overweight/obesity (OW/OB) women. Alterations in the serum NTN4 level were examined during the cold-exposure tests, acute exercise, lipid infusion, OGTT and EHC.
RESULTS
GWAS and Bioinformatics analysis revealed that NTN4 was closely related to energy metabolism and OS. In a population-based cohort study, we observed that individuals with OW/OB and IR exhibited significantly elevated levels of circulating NTN4. In addition, the serum NTN4 concentration was found to be significantly correlated with indicators of obesity, IR, sex hormone and glucose/lipid metabolism.
CONCLUSIONS
NTN4 is associated with obesity-related IR.
TRIAL REGISTRATION
All research plans were approved by the Human Research Ethics Committee of Chongqing Medical University (No. (74)2012, No. (72)2014 and No. (74)2015).
Collapse